Clinical Trial Update: Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating efficacy/safety of trifluridine/tipiracil plus irinotecan for advanced refractory biliary tract cancer; results posted after completion o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer
• Gallbladder Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-09-22